Navigation Links
135-90 Mid Range Power Supplies

Products135-90 Mid Range Power Supplies
Company ThermoFisher Scientific
Item 135-90 Mid Range Power Supplies
Features 
  • Manage Your Time Better: The mid range power supplies all have a dual-function, 100-hour timer that completes the experiment at the end of the time interval. This convenient timer also accrues elapsed time as the experiment progresses. This product has proven to be simple and efficient in assisting the user to better manage time.
  • Easy-to-Use: Designed with the simplicity in mind - a single knob controls the output and a single pushbutton selects the mode to be adjusted. Bright LED displays provide continuous information as it relates to output voltage, current and elapsed time. For added convenience, the power supplies remembers its last settings and comes equipped with a power fail memory.
  • Automatic Crossover Protects Your System: The automatic crossover function allows the power supply to switch over from one mode of operation to the other when the preset limit is reached, protecting your system and experiment.
  • Holding Voltage: This unique feature simplifies every experiment. It is designed to provide the operator with the option of applying a small voltage to the gel at the end of a timed experiment. This holding voltage minimizes sample diffusion prior to the disassembly of the electrophoresis apparatus.
Description Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus.
Info ThermoFisher Scientific
Web site: http://www.thermo.com
Web site: http://www.thermofisher.com/global/en/home.asp

Related medicine products :

1. Genu-Ranger® Hinged Range of Motion Knee Brace
2. Bivona® Mid-Range Aire-Cuf® Adjustable Neck Flange Hyperflex™ Tracheostomy Tubes
3. Bivona® Mid-Range Aire-Cuf® Tracheostomy Tubes
4. Bivona® Mid-Range Aire-Cuf® and Fome-Cuf® Tracheostomy Tubes with Talk Attachment
5. Cortisol Range Verifiers
6. AlphaPette Pipettor - Range 100l - 1000l
7. AlphaPette Pipettor - Range 20l - 200l
8. AlphaPette Pipettor - Range 2l - 20l
9. AlphaPette Pipettor - Range 0.5l - 10l
10. AlphaPette Pipettor - Range 10l - 100l
11. NC Ranger™ Balloon Catheter
Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube
Indications For Usage: , ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hou
Indications For Usage:, ,Single use on tracheostomy patients who can breathe spontaneously. The product is intended to be replaced at least once every 24 hours.
...eg; Thermovent® T helps provide protection to ... is small and extremely lightweight making it idea...h a high rate of heat and moisture recovery, it en...ion., ,All HMEs and filters have ISO standard tap...
Medicine Products:
(Date:9/5/2008)...ane Shows Public Reluctant to Evacuate, Without Th...forts Confirm Survey R...rvey by the American Humane,Association found that...tance if it meant leaving without their family pet...towards the U.S. coast, residents and,officials sh...
(Date:9/5/2008)...swire/ -- Arthrosurface, Inc.,( http://www.arthros...,resurfacing systems, announced that it has receiv... investigation for its line of focal knee,resurfac...tstanding safety,concerns" with the device and gra...n evaluating the safety and efficacy of its,HemiCA...
(Date:9/5/2008)...swire/ -- On Saturday, September 6, PARI,Respirato...k show Today,s,Family as part of their "Breathe Ea...ical device company that provides patients, such a...mpressors that deliver needed,medications directly...es of those affected by respiratory,diseases and t...
(Date:9/5/2008)...ose overweight or obese at age 45 , , FR...ll American adults will develop osteoarthritis of ...y are obese in middle age, a new study says. ,...ncreased as his or her body-mass index (BMI) rose,...Chapel Hill study. People who were of normal weigh...
Breaking Medicine News(10 mins):Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Arthrosurface HemiCAP(R) Focal Knee Resurfacing Implant Receives FDA Approval to Move into Final Investigational Stage 2Health News:PARI Respiratory Equipment Featured on Oxygen Network 2Health News:Almost Half of Adults Will Develop Knee Osteoarthritis by 85 2
... the workplace faced by women doctors and nurses h...are not ready to come out openly against it.// A ...th 135 in-depth interviews of women employees in t...s over a period of 11 months, has brought out this...
...ess Day falls on November 7 and the theme selected...will be participating in a marathon on that day// ...ands against the dreaded disease. "Run 4 Cancer" ... Meena, from Kamala Nehru Memorial Hospital. Commi...
... for its lax regulations regarding booze often fin...liquor without any person// in authority ever rais... surprise when recent estimates prove that over fo...ders which are linked to alcoholism. However a clo...
...otechnology firm based in Seattle has called off f...itiated early this year following the untimely dea...g in the clinical trial to prove the efficacy of t...company James Bianco has reiterated that the death...
Other Medicine News:Health News:Doctors, Nurses Face Sexual Harassment At Work Place 2Health News:Awareness about Women's Cancers- A National Concern 2Health News:Multiple deaths forces cancer trial to be called off 2
(Date:9/5/2008)... VIENNA, Va., Sept. 5 /...y that it presented new rheumatoid arthritis data,...n Amsterdam. The data,presented by Dr. Daniel Zim...r Immunology of CEL-SCI, indicate that CEL-SCI,s r...etards the permanent tissue damage,caused by rheum...
(Date:9/5/2008)... MORGANTOWN, W.Va., Sept. 5 /PRNewswire-USNews...iversity has shown that U.S. immigrants from,India...country, increasing,their risks of prostate cancer...ales., "Breast cancer and prostate cancer develop...d lifestyle play a major role in these cancers,",s...
(Date:9/4/2008)... MELBOURNE, Australia, Sept. 4 /-...t is commencing enrolment for its Phase Ib/II,stud...ng anticancer agent,in patients with an aggressiv...forme (GBM)., The GBM clinical trial is the first... tumor indications for the company and the second ...
(Date:9/4/2008)... SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstC...ay announced that the pivotal clinical study of,Po...,s partner, Chemische,Fabrik KREUSSLER & Co. GmbH ...dpoint and has been submitted to FDA as part of a ...al clinical study, named the EASI (Efficacy and sa...
Breaking Medicine Technology:Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 1Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 2Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 3Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 4Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material Including Lorcaserin 2258 5BMI criteria for obesity surgery should be lowered UT Southwestern researcher suggests 1635 1BMI criteria for obesity surgery should be lowered UT Southwestern researcher suggests 1635 2California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System 8432 1California Breakthrough a Pivotal Moment in Fight to Transform Nations Health Care System 8432 2GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 1GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 2GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine 8429 3
...ization and drug withdrawal, CHICAGO, May 15, 2007...ine patients and physicians commissioned by the Na... Interactive shows that,20 percent of migraine pat...edications that contain barbiturates or opioids an... Administration for the,relief of migraines. , Mig...
... of clinical data on leading,drug-eluting stent po...irstCall/ -- Boston,Scientific Corporation today a...s and press announcements at the annual Paris,Cour... from May 22,to 25 in Barcelona, Spain. , "We will...al,trials and registries, adding to the knowledge ...
Other Medicine Technology:Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 2Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 3Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 4Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 5Survey: Migraine Patients Taking Potentially Addictive Barbiturate,or Opioid Medications Not Approved by FDA as Migraine Treatments 6Boston Scientific Announces Schedule for EuroPcr 2007 2Boston Scientific Announces Schedule for EuroPcr 2007 3Boston Scientific Announces Schedule for EuroPcr 2007 4Boston Scientific Announces Schedule for EuroPcr 2007 5